港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

生物医药B类股

570.136

-12.792-2.19%

涨家数：7

跌家数：26

平家数：1

市盈率：- -

高：587.289

开：582.929

低：558.320

收：582.929

数据加载中...

IL-25：II型炎症通路创新靶点剑指百亿美元特应性皮炎市场

AMAC医药制造指数上涨0.64%，前十大权重包含百济神州等

绝望的绿谷医药：“神药”竟只是测试版

【转|太平洋医药-信达生物深度】肿瘤、代谢、自免、眼科四象并驱的全球化Biopharma

钟南山院士力挺！众生药业创新药研发迎来“收获期”，股价反弹超61%

电生理布局！先健1.5亿元投资剑虎

MedTrend医趋势

创新药走势这么牛，背后推手是谁？

公司研究室

康诺亚生物计划配股融资不超1.021亿美元

中办、国办：探索将国际新药临床真实世界数据用于进口药品注册上市许可的可行路径

和铂医药-B(02142)委任刘毅为联席公司秘书

新产业：全自动化学发光免疫分析仪获注册证

翰思艾泰二次冲击港股IPO：亏损持续扩大、创新药研发不易、管线商业化遥遥无期

《理财周刊》

复星商业报告｜出海全世界，复星的生物医药创新从上海出发

天士力：硫酸氨基葡萄糖胶囊获药品注册证书

每日卖空追踪 | 沛嘉医疗-B 06月10日卖空量成交7.4万股，卖空比例为2.1%

每日卖空追踪 | 荣昌生物 06月10日卖空量成交128.05万股，卖空比例为9.21%

每日卖空追踪 | 诺诚健华 06月10日卖空量成交204.5万股，卖空比例为6.28%

每日卖空追踪 | 再鼎医药 06月10日卖空量成交128.47万股，卖空比例为5.69%

每日卖空追踪 | 康方生物 06月10日卖空量成交172.3万股，卖空比例为5.22%

每日卖空追踪 | 归创通桥 06月10日卖空量成交1.7万股，卖空比例为2.48%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK1574/news?page=11"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物医药B类股","latestPrice":570.13635,"timestamp":1749802087763,"preClose":582.92883,"halted":0,"volume":380175488,"delay":0,"changeRate":-0.021945,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":-12.79248,"latestTime":"06-13 16:00:00","open":582.92883,"high":587.289,"low":558.3201,"amount":8643935996,"amplitude":0.049695,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1750037400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1749778200000,1749787200000],[1749790800000,1749801600000]],"pbRate":4.675817,"peRate":-28.799987,"turnoverRate":0.014292,"increases":7,"decrements":26,"flats":0,"marketCap":332995831168,"floatMarketCap":305114398560},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":587.289,"amplitude":0.049695,"preClose":582.92883,"low":558.3201,"pbRate":"4.675817","latestPrice":570.13635,"volume":380175488,"delay":0,"open":582.92883,"prevYearClose":331.1933,"prevWeekClose":504.495,"prevMonthClose":491.683,"prevQuarterClose":455.082,"fiveDayClose":504.495,"twentyDayClose":454.964,"sixtyDayClose":426.424,"secType":"PLATE","market":"HK","turnoverRate":0.014292,"peRate":-28.799987,"marketCap":332995831168,"floatMarketCap":305114398560,"timestamp":1749802087763,"nameCN":"生物医药B类股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":7,"down":26,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:11,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2542814025","title":"IL-25：II型炎症通路创新靶点 剑指百亿美元特应性皮炎市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2542814025","media":"长江证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542814025?lang=zh_cn&edition=fundamental","pubTime":"2025-06-11 00:00","pubTimestamp":1749571200,"startTime":"0","endTime":"0","summary":"IL-25l：II型炎症通路 新靶点，与多种皮肤疾病病理有关白细胞介素-17E是IL-17 细胞因子家族的成员，该家族包括IL-17A 至IL-17F，在宿主防御反应和炎症疾病中发挥关键作用。研究发现，IL-25 在特应性皮炎 、银屑病和接触性皮炎这几种皮肤炎症疾病的病变组织中均有上调，表明其与这几种疾病的发展有关，该靶点具备多适应症探索潜力。我们认为，IL-25 有望成为特应性皮炎市场的下一个重磅靶点，并且还具有拓展至其他II 型炎症适应症的潜力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611200301a4a37d29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611200301a4a37d29&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","03681","BK1574"],"gpt_icon":0},{"id":"2542343192","title":"AMAC医药制造指数上涨0.64%，前十大权重包含百济神州等","url":"https://stock-news.laohu8.com/highlight/detail?id=2542343192","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542343192?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 22:38","pubTimestamp":1749566332,"startTime":"0","endTime":"0","summary":"金融界6月10日消息，上证指数高开低走，AMAC医药制造指数 上涨0.64%，报4507.44点，成交额1008.07亿元。数据统计显示，AMAC医药制造指数近一个月上涨10.73%，近三个月上涨13.98%，年至今上涨13.45%。从指数持仓来看，AMAC医药制造指数十大权重分别为：恒瑞医药、片仔癀、云南白药、科伦药业、长春高新、新和成、复星医药、常山药业、上海莱士、百济神州。从AMAC医药制造指数持仓样本的行业来看，医药卫生占比98.09%、主要消费占比1.91%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/10223850989112.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["399233","LU2328871848.SGD","ONC","BK4139","06160","LU0307460666.USD","BK4526","09939","LU1969619763.USD","BK0239","688235","159938","BK1500","BK1161","BK1574","BK1583","BK1515","LU0588546209.SGD","BK1588"],"gpt_icon":0},{"id":"2542334800","title":"绝望的绿谷医药：“神药”竟只是测试版","url":"https://stock-news.laohu8.com/highlight/detail?id=2542334800","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542334800?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 22:14","pubTimestamp":1749564840,"startTime":"0","endTime":"0","summary":"　　　6月9日，绿谷医药证实：已停止阿尔茨海默症药物甘露特钠胶囊的生产，并计划关闭相关办公和生产区域。停产期间，员工按上海市最低工资标准发放，社保公积金按正常缴纳。现在的绿谷就不好惹。　　在这之前，绿谷已经“将”了国家药监局一军。但实际绿谷负责生产和营销。　　绿谷官方表述，971停产的主要原因是“药品注册证已到期，新的审批尚未通过”。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/med/2025-06-10/doc-inezrake8805343.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159938","09939","BK1574","BK1161","BK1515"],"gpt_icon":0},{"id":"2542100503","title":"【转|太平洋医药-信达生物深度】肿瘤、代谢、自免、眼科四象并驱的全球化Biopharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2542100503","media":"远峰电子","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542100503?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 21:46","pubTimestamp":1749563188,"startTime":"0","endTime":"0","summary":"文章转自2025年04月14日太平洋医药团队报告，分析师：周豫/霍亮/戎晓婕投资要点信达生物是国内领先的Biopharma，核心推荐逻辑如下：1）公司商业化能力已得到验证，产品收入有望保持高速增长。15款已上市产品将贡献稳定增长的现金流，肥胖、糖尿病及银屑病大适应症获批将陆续落地。2）肿瘤免疫双抗和ADC具备全球竞争力。信达生物前五大股东持股比例为21%，港股通持股占比31%。截止2025年4月3日，港股通持股占总股本比例为31.27%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610215302a7023ec6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610215302a7023ec6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01801","LU2328871848.SGD","LU1969619763.USD","09939","BK1574","LU2488822045.USD","BK1589","BK1583","BK1515"],"gpt_icon":0},{"id":"2542900310","title":"钟南山院士力挺！众生药业创新药研发迎来“收获期”，股价反弹超61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542900310","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542900310?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 21:44","pubTimestamp":1749563079,"startTime":"0","endTime":"0","summary":"一度下跌70%","market":"sg","thumbnail":"https://img3.gelonghui.com/a3c56-1d8aed28-7834-4387-aa12-fe38fedc5da0.jpg?guru_height=718&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/a3c56-1d8aed28-7834-4387-aa12-fe38fedc5da0.jpg?guru_height=718&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/2305863","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK0188","BK0239","06978","BK0077","002317","BK1574","BK1161"],"gpt_icon":0},{"id":"2542231602","title":"电生理布局！先健1.5亿元投资剑虎","url":"https://stock-news.laohu8.com/highlight/detail?id=2542231602","media":"MedTrend医趋势","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542231602?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 18:45","pubTimestamp":1749552342,"startTime":"0","endTime":"0","summary":"6月9日，先健科技宣布拟通过其全资子公司先健深圳，以1.5亿元人民币分阶段投资剑虎医疗科技(苏州)有限公司。01投资1.5亿元加码电生理赛道根据协议，先健科技将分阶段向剑虎医疗注资1.5亿元，首阶段完成后将获得22.22%股权，剩余投资将在剑虎医疗完成特定里程碑事件后完成，包括核心团队与先健深圳签订雇佣合同、保密协议及不竞争协议，以及取得特定产品的国家药监局注册证书。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610190239a7020bae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610190239a7020bae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1100","01302","BK1600","BK1574","09997","BK1222","09996"],"gpt_icon":0},{"id":"2542315592","title":"创新药走势这么牛，背后推手是谁？","url":"https://stock-news.laohu8.com/highlight/detail?id=2542315592","media":"公司研究室","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542315592?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 18:34","pubTimestamp":1749551645,"startTime":"0","endTime":"0","summary":"截至收盘，A股创新药板块年内涨幅30.80%，而沪深300同期下跌1.78%。那么，创新药走势这么牛，背后推手又是谁呢？从创新药涨幅前10 看，H股有4只，A股创业板、科创板、北交所各2只。整体而言，在这波创新药上涨行情中，H股扛大旗的是财大气粗的外资机构，A股冲锋在前的自然是公募基金。显然，在这波创新药行情中，这些创新药牛股与重仓基金可谓相互成就。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610183700a7020374&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610183700a7020374&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688331","688428","09995","688382","06978","01530","02587","09926","688506","688266","BK1161","03692","BK1574","BK1191","01276","06990","01801","600276"],"gpt_icon":1},{"id":"2542315547","title":"康诺亚生物计划配股融资不超1.021亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542315547","media":"DoNews","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542315547?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 18:17","pubTimestamp":1749550622,"startTime":"0","endTime":"0","summary":"6月10日，康诺亚生物披露文件显示，公司拟以每股45.34至46.31港元的价格配售1730万股股票，寻求融资不超过1.021亿美元。此次配股旨在优化资本结构并支持业务发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061018191397793ecb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061018191397793ecb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1583","BK1574","02162","BK1587"],"gpt_icon":0},{"id":"2542390964","title":"中办、国办：探索将国际新药临床真实世界数据用于进口药品注册上市许可的可行路径","url":"https://stock-news.laohu8.com/highlight/detail?id=2542390964","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542390964?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 17:59","pubTimestamp":1749549598,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["09996","BK1100","BK1583","09997","159883","BK1222","BK1574"],"gpt_icon":0},{"id":"2542139069","title":"和铂医药-B(02142)委任刘毅为联席公司秘书","url":"https://stock-news.laohu8.com/highlight/detail?id=2542139069","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542139069?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 17:51","pubTimestamp":1749549113,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和铂医药-B(02142)发布公告，于2025年6月9日，董事会已批准委任刘毅，Ph.D.、J.D.为公司联席公司秘书，自2025年6月9日开始生效。公司的现任公司秘书吕颖一先生将为公司的另一名联席公司秘书。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1303519.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1161","02142","BK1574"],"gpt_icon":0},{"id":"2542929093","title":"新产业：全自动化学发光免疫分析仪获注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2542929093","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542929093?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 17:30","pubTimestamp":1749547859,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["09996","BK0239","BK1100","300832","159883","BK1574","BK1583","BK1222","09997"],"gpt_icon":0},{"id":"2542039019","title":"翰思艾泰二次冲击港股IPO：亏损持续扩大、创新药研发不易、管线商业化遥遥无期","url":"https://stock-news.laohu8.com/highlight/detail?id=2542039019","media":"《理财周刊》","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542039019?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 17:22","pubTimestamp":1749547320,"startTime":"0","endTime":"0","summary":"翰思艾泰曾于2024年11月24日首次递交上市申请，6个月后申请失效故再次提交。不少投资者都相当关注翰思艾泰的此次上市。据招股说明书介绍，目前翰思艾泰专注于研发及商业化用于癌症及自身免疫疾病精准治疗的产品。图源：翰思艾泰招股说明书一般来说，新药研发分为5个临床阶段：0期、I期、Ⅱ期、Ⅲ期、IV期。而据翰思艾泰招股说明书披露，目前已开发了十种候选药物组成的管线。在2023年和2024年，翰思艾泰分别亏损8462.3万元及1.17亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-06-10/doc-inezqruk8979016.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159992","YANG","BK1574","BK4614","HSTECH","06978","BK1161"],"gpt_icon":1},{"id":"2542394030","title":"复星商业报告｜出海全世界，复星的生物医药创新从上海出发","url":"https://stock-news.laohu8.com/highlight/detail?id=2542394030","media":"复星医药","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542394030?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 17:02","pubTimestamp":1749546132,"startTime":"0","endTime":"0","summary":"然而，复星的创新药不仅打破了“双十定律”，如今出海50多个国家和地区，实现了从“中国新”到“全球新” 的飞跃。出海全球，从上海起航对于生物医药而言，仅仅有研发能力还无法持续发展，出海是中国创新药发展的重要路径。另一方面，位于上海的生产基地则是复星生物药出海背后的“基石”。将生产基地设在上海，不仅能够受益上海生物医药集群的产业优势，也能够受益于上海的人才优势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610171211a701de03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610171211a701de03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600196","BK1574","06978","BK1161","BK1230","02196","00656"],"gpt_icon":0},{"id":"2542915393","title":"天士力：硫酸氨基葡萄糖胶囊获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2542915393","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542915393?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 16:54","pubTimestamp":1749545671,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["600535","01477","BK1191","BK0028","BK0196","BK0183","BK0239","BK1574","BK0012","BK0188"],"gpt_icon":0},{"id":"2542313197","title":"每日卖空追踪 | 沛嘉医疗-B 06月10日卖空量成交7.4万股，卖空比例为2.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542313197","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542313197?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 16:30","pubTimestamp":1749544241,"startTime":"0","endTime":"0","summary":"沛嘉医疗-B北京时间06月10日，涨5.27%，卖空量成交7.4万股%，较上一交易日减少48.61%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610175835a701f3d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610175835a701f3d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1100","BK1583","09996"],"gpt_icon":0},{"id":"2542158318","title":"每日卖空追踪 | 荣昌生物 06月10日卖空量成交128.05万股，卖空比例为9.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542158318","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542158318?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 16:30","pubTimestamp":1749544241,"startTime":"0","endTime":"0","summary":"荣昌生物北京时间06月10日，涨3.79%，卖空量成交128.05万股%，较上一交易日增加117.96%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610175842a701f3de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610175842a701f3de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2328871848.SGD","LU1969619763.USD","BK1161","09995","BK1574","BK1583"],"gpt_icon":0},{"id":"2542156843","title":"每日卖空追踪 | 诺诚健华 06月10日卖空量成交204.5万股，卖空比例为6.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542156843","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542156843?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 16:30","pubTimestamp":1749544241,"startTime":"0","endTime":"0","summary":"诺诚健华北京时间06月10日，涨0.91%，卖空量成交204.5万股%，较上一交易日减少69.25%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610175836a701f3d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610175836a701f3d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09969","BK1161","BK1574"],"gpt_icon":0},{"id":"2542313152","title":"每日卖空追踪 | 再鼎医药 06月10日卖空量成交128.47万股，卖空比例为5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542313152","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542313152?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 16:30","pubTimestamp":1749544240,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间06月10日，涨3.87%，卖空量成交128.47万股%，较上一交易日减少21.67%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610175818a4a1bfa8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610175818a4a1bfa8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1588","BK1161","LU2488822045.USD","09688","BK1574"],"gpt_icon":0},{"id":"2542189713","title":"每日卖空追踪 | 康方生物 06月10日卖空量成交172.3万股，卖空比例为5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542189713","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542189713?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 16:30","pubTimestamp":1749544240,"startTime":"0","endTime":"0","summary":"康方生物北京时间06月10日，涨10.43%，卖空量成交172.3万股%，较上一交易日增加41.35%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610175834a701f3cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610175834a701f3cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09926","IE00BPRC5H50.USD","LU0348783233.USD","IE00B543WZ88.USD","LU0417516571.SGD","IE00B5MMRT66.SGD","BK1161","LU1794554557.SGD","LU1720050803.USD","LU2488822045.USD","LU0348784397.USD","BK1574"],"gpt_icon":0},{"id":"2542313942","title":"每日卖空追踪 | 归创通桥 06月10日卖空量成交1.7万股，卖空比例为2.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542313942","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542313942?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 16:30","pubTimestamp":1749544229,"startTime":"0","endTime":"0","summary":"归创通桥北京时间06月10日，涨2.05%，卖空量成交1.7万股%，较上一交易日减少75.18%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610175432a701f224&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610175432a701f224&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1587","02190","BK1583","BK1100"],"gpt_icon":0}],"pageSize":20,"totalPage":35,"pageCount":11,"totalSize":697,"code":"91000000","status":"200"}]}}